4bdd: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)== | ==Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)== | ||
<StructureSection load='4bdd' size='340' side='right' caption='[[4bdd]], [[Resolution|resolution]] 2.67Å' scene=''> | <StructureSection load='4bdd' size='340' side='right'caption='[[4bdd]], [[Resolution|resolution]] 2.67Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4bdd]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BDD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4BDD FirstGlance]. <br> | <table><tr><td colspan='2'>[[4bdd]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BDD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4BDD FirstGlance]. <br> | ||
| Line 30: | Line 30: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Large Structures]] | |||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
[[Category: Aherne, G W]] | [[Category: Aherne, G W]] | ||